[Myasthenia with monoclonal kappa IgM gammapathy and presence of anti-striated muscle antibodies].
D000368:Aged; D000549:Ambenonium Chloride / Q000627:therapeutic use; D000906:Antibodies / Q000032:analysis; D002852:Chromatography, Ion Exchange; D004586:Electrophoresis; D005132:Eye Manifestations; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007122:Immunoelectrophoresis; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis*; D009132:Muscles / Q000276:immunology; D009157:Myasthenia Gravis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology* / Q000652:urine; D009388:Neostigmine
D000906:Antibodies; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D009388:Neostigmine; D000549:Ambenonium Chloride
Myasthénie avec gammapathie monoclonale IgM kappa et présence d'anticorps antimuscles striés.